POLYNEUROPATHIES
Clinical trials for POLYNEUROPATHIES explained in plain language.
Never miss a new study
Get alerted when new POLYNEUROPATHIES trials appear
Sign up with your email to follow new studies for POLYNEUROPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One Man's own cells tested to fight rare nerve disease
Disease control NO_LONGER_AVAILABLEThis was a special access program for one 58-year-old man with severe nerve damage (polyneuropathy) caused by a rare condition called POEMS syndrome. The goal was to see if eight infusions of his own banked stem cells, given over 28 weeks, were safe and could help relieve his sym…
Matched conditions: POLYNEUROPATHIES
Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
One-Shot gene therapy aims to halt rare, devastating nerve disease
Disease control OngoingThis Phase 3 trial is testing whether a single dose of an experimental gene therapy called NTLA-2001 can safely slow or stop the progression of hereditary amyloidosis with polyneuropathy (ATTRv-PN), a rare genetic disease that damages nerves. About 50 participants worldwide will …
Matched conditions: POLYNEUROPATHIES
Phase: PHASE3 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early trial tests drug for debilitating nerve damage in rare heart condition
Disease control OngoingThis small, early-phase study is testing whether the drug patisiran can help control nerve damage in people with wild-type ATTR amyloidosis, a rare condition where abnormal proteins build up in the body. Ten participants with nerve symptoms will receive patisiran infusions every …
Matched conditions: POLYNEUROPATHIES
Phase: EARLY_PHASE1 • Sponsor: Austin Neuromuscular Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC